keyword
https://read.qxmd.com/read/38604542/how-future-pharmacological-therapies-for-celiac-disease-will-complement-the-gluten-free-diet
#21
JOURNAL ARTICLE
Valentina Discepolo, Ciarán P Kelly, Frits Koning, Detlef Schuppan
The only proven treatment for celiac disease is adherence to a strict, lifelong, gluten free diet. However, complete dietary gluten avoidance is challenging and a substantial number of patients do not respond fully, clinically or histologically, despite their best efforts. As celiac disease is common and its central pathophysiology is well elucidated, it has become attractive for drug development to address the limitations of dietary treatment. Most efforts address non-responsive celiac disease, defined as continued symptoms and/or signs of disease activity despite a gluten free diet, including the more severe forms of refractory celiac disease type 1 and 2...
April 9, 2024: Gastroenterology
https://read.qxmd.com/read/38604293/white-adipose-tissue-in-metabolic-associated-fatty-liver-disease
#22
REVIEW
Xiaoqin Zhu, Chuanfei Zeng, Baoping Yu
BACKGROUND: Metabolic associated fatty liver disease (MAFLD) is a prevalent chronic liver condition globally, currently lacking universally recognized therapeutic drugs, thereby increasing the risk of cirrhosis and hepatocellular carcinoma. Research has reported an association between white adipose tissue and MAFLD. SCOPE OF REVIEW: White adipose tissue (WAT) is involved in lipid metabolism and can contribute to the progression of MAFLD by mediating insulin resistance, inflammation, exosomes, autophagy, and other processes...
April 9, 2024: Clinics and Research in Hepatology and Gastroenterology
https://read.qxmd.com/read/38604221/-phytotherapeutic-recommendations-in-medical-guidelines-for-the-treatment-of-gastroenterological-diseases-a-systematic-review
#23
JOURNAL ARTICLE
Sandra Utz, Miriam Bittel, Jost Langhorst
Phytotherapeutics are gaining influence in the treatment of gastroenterological diseases. Their popularity and growing evidence of efficacy contribute to their integration into medical guidelines. A systematic screening identified recommended phytotherapeutic approaches. Based on current scientific data, some recommendations for the use of phytotherapeutic agents are given. For <u>irritable bowel syndrome</u> the use of peppermint oil is "strongly recommended", especially for pain and flatulence...
April 11, 2024: Zeitschrift Für Gastroenterologie
https://read.qxmd.com/read/38604200/fine-tuning-the-gut-ecosystem-the-current-landscape-and-outlook-of-artificial-microbiome-therapeutics
#24
REVIEW
Serena Porcari, William Fusco, Igor Spivak, Marcello Fiorani, Antonio Gasbarrini, Eran Elinav, Giovanni Cammarota, Gianluca Ianiro
The gut microbiome is acknowledged as a key determinant of human health, and technological progress in the past two decades has enabled the deciphering of its composition and functions and its role in human disorders. Therefore, manipulation of the gut microbiome has emerged as a promising therapeutic option for communicable and non-communicable disorders. Full exploitation of current therapeutic microbiome modulators (including probiotics, prebiotics, and faecal microbiota transplantation) is hindered by several factors, including poor precision, regulatory and safety issues, and the impossibility of providing reproducible and targeted treatments...
May 2024: Lancet. Gastroenterology & Hepatology
https://read.qxmd.com/read/38601269/advanced-diagnostic-endoscopy-in-the-upper-gastrointestinal-tract-review-of-the-japan-gastroenterological-endoscopic-society-core-sessions
#25
JOURNAL ARTICLE
Hiroya Ueyama, Toshiaki Hirasawa, Tomonori Yano, Hisashi Doyama, Hajime Isomoto, Kazuyoshi Yagi, Takashi Kawai, Kenshi Yao
The Japan Gastroenterological Endoscopy Society (JGES) held four serial symposia between 2021 and 2022 on state-of-the-art issues related to advanced diagnostic endoscopy of the upper gastrointestinal tract. This review summarizes the four core sessions and presents them as a conference report. Eleven studies were discussed in the 101st JGES Core Session, which addressed the challenges and prospects of upper gastroenterological endoscopy. Ten studies were also explored in the 102nd JGES Core Session on advanced upper gastrointestinal endoscopic diagnosis for decision-making regarding therapeutic strategies...
April 2024: DEN Open
https://read.qxmd.com/read/38599835/-current-status-of-diagnosis-and-drainage-in-biliary-stenosis-lesions
#26
JOURNAL ARTICLE
Hiroki Kawashima, Takuya Ishikawa, Kentaro Yamao
No abstract text is available yet for this article.
2024: Nihon Shokakibyo Gakkai Zasshi, the Japanese Journal of Gastro-enterology
https://read.qxmd.com/read/38598642/advances-in-endoscopic-management-of-colonic-diverticular-bleeding
#27
JOURNAL ARTICLE
Yasutoshi Shiratori, Syed Matthew Kodilinye, Ahmed E Salem
PURPOSE OF REVIEW: This review is focused on diagnostic and management strategies for colonic diverticular bleeding (CDB). It aims to present the current state of the field, highlighting the available techniques, and emphasizing findings that influence the choice of therapy. RECENT FINDINGS: Recent guidelines recommend nonurgent colonoscopy (>24 h) for CDB. However, factors such as a shock index ≥1, which may warrant an urgent colonoscopy, remain under investigation...
April 11, 2024: Current Opinion in Gastroenterology
https://read.qxmd.com/read/38597333/selecting-first-line-advanced-therapy-for-ulcerative-colitis-a-clinical-application-of-personalized-medicine
#28
JOURNAL ARTICLE
Mariam S Mukhtar, Mahmoud H Mosli
Ulcerative colitis (UC) is a chronic autoimmune inflammatory disease that affects the colon, leading to symptoms of bloody diarrhea, abdominal cramps, and urgency. The treatment of UC has evolved over the past few decades from locally active anti-inflammatory compounds to more selective therapies that target specific arrays of the immune system. The challenge of selecting the first advanced therapy became apparent in this rapidly expanding landscape of medications. No current investigational tools, such as genetic, immunologic, or biological markers, can guide the identification of the safest and most effective therapeutic option for each patient...
April 10, 2024: Saudi Journal of Gastroenterology: Official Journal of the Saudi Gastroenterology Association
https://read.qxmd.com/read/38596807/perceptions-and-prevalence-of-cannabis-use-in-women-with-inflammatory-bowel-disease-of-reproductive-age-a-cross-sectional-study
#29
JOURNAL ARTICLE
Nariman Hossein-Javaheri, Katie O'Connor, Hillary Steinhart, Amol Deshpande, Cynthia Maxwell, Vivian Huang, Parul Tandon
BACKGROUND: Many patients with inflammatory bowel disease (IBD) may use cannabis for relief of symptoms. During pregnancy, however, cannabis exposure may be associated with adverse pregnancy outcomes. We aimed to determine the prevalence and perceptions of cannabis use in women with IBD. METHODS: Through recruitment at Mount Sinai Hospital and online platforms such as Twitter, women with IBD (age 18-45) were asked to complete anonymous surveys on demographics, cannabis use, perception of use during pregnancy, and discussing its use with healthcare providers (HCP)...
April 2024: Journal of the Canadian Association of Gastroenterology
https://read.qxmd.com/read/38596806/endoscopic-retrograde-cholangiopancreatography-under-general-anesthesia-compared-to-conscious-sedation-study
#30
JOURNAL ARTICLE
Grant Greaves, Kaitlyn G Harding, Brent Parker, Vu C Nguyen, Azim Ahmed, Belinda Yee, Joël Perren, Mathew Norman, Morgan Grey, Rafael Perini, Fahd Jowhari, Adrian Bak
BACKGROUND: Endoscopic retrograde cholangiopancreatography (ERCP) is used to diagnose and treat pancreatic and biliary disease. The current standard is to conduct ERCP under conscious sedation (CS). Patient movement and agitation during ERCP under CS can result in procedure failure and complications. Aiming to reduce procedure failure rates and complications, Kelowna General Hospital (KGH) in British Columbia, Canada transitioned to performing ERCP under general anesthesia (GA) as the practice standard...
April 2024: Journal of the Canadian Association of Gastroenterology
https://read.qxmd.com/read/38596504/optimizing-prediction-models-for-pancreatic-fistula-after-pancreatectomy-current-status-and-future-perspectives
#31
REVIEW
Feng Yang, John A Windsor, De-Liang Fu
Postoperative pancreatic fistula (POPF) is a frequent complication after pancreatectomy, leading to increased morbidity and mortality. Optimizing prediction models for POPF has emerged as a critical focus in surgical research. Although over sixty models following pancreaticoduodenectomy, predominantly reliant on a variety of clinical, surgical, and radiological parameters, have been documented, their predictive accuracy remains suboptimal in external validation and across diverse populations. As models after distal pancreatectomy continue to be progressively reported, their external validation is eagerly anticipated...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38596501/capsule-endoscopy-and-panendoscopy-a-journey-to-the-future-of-gastrointestinal-endoscopy
#32
EDITORIAL
Bruno Rosa, José Cotter
In 2000, the small bowel capsule revolutionized the management of patients with small bowel disorders. Currently, the technological development achieved by the new models of double-headed endoscopic capsules, as miniaturized devices to evaluate the small bowel and colon [pan-intestinal capsule endoscopy (PCE)], makes this non-invasive procedure a disruptive concept for the management of patients with digestive disorders. This technology is expected to identify which patients will require conventional invasive endoscopic procedures (colonoscopy or balloon-assisted enteroscopy), based on the lesions detected by the capsule, i...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38596498/optimizing-nutrition-in-hepatic-cirrhosis-a-comprehensive-assessment-and-care-approach
#33
REVIEW
Osvely Mendez-Guerrero, Anaisa Carranza-Carrasco, Luis Alberto Chi-Cervera, Aldo Torre, Nalu Navarro-Alvarez
Cirrhosis is considered a growing cause of morbidity and mortality, which represents a significant public health problem. Currently, there is no effective treatment to reverse cirrhosis. Treatment primarily centers on addressing the underlying liver condition, monitoring, and managing portal hypertension-related complications, and evaluating the potential for liver transplantation in cases of decompensated cirrhosis, marked by rapid progression and the emergence of complications like variceal bleeding, hepatic encephalopathy, ascites, malnutrition, and more...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38596496/preliminary-exploration-of-animal-models-of-congenital-choledochal-cysts
#34
JOURNAL ARTICLE
Shu-Hao Zhang, Yue-Bin Zhang, Duo-Te Cai, Tao Pan, Ken Chen, Yi Jin, Wen-Juan Luo, Zong-Wei Huang, Qing-Jiang Chen, Zhi-Gang Gao
BACKGROUND: Various animal models have been used to explore the pathogenesis of choledochal cysts (CCs), but with little convincing results. Current surgical techniques can achieve satisfactory outcomes for treatment of CCs. Consequently, recent studies have focused more on clinical issues rather than basic research. Therefore, we need appropriate animal models to further basic research. AIM: To establish an appropriate animal model that may contribute to the investigation of the pathogenesis of CCs...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38596495/vonoprazan-amoxicillin-dual-regimen-with-saccharomyces-boulardii-as-a-rescue-therapy-for-helicobacter-pylori-current-perspectives-and-implications
#35
EDITORIAL
Valerie Josephine Dirjayanto, Jessica Audrey, Daniel Martin Simadibrata
Yu et al 's study in the World Journal of Gastroenterology (2023) introduced a novel regimen of Vonoprazan-amoxicillin dual therapy combined with Saccharomyces boulardii ( S. boulardii ) for the rescue therapy against Helicobacter pylori ( H. pylori ) , a pathogen responsible for peptic ulcers and gastric cancer. Vonoprazan is a potassium-competitive acid blocker renowned for its rapid and long-lasting acid suppression, which is minimally affected by mealtime. Compared to proton pump inhibitors, which bind irreversibly to cysteine residues in the H+ /K+ -ATPase pump, Vonoprazan competes with the K+ ions, prevents the ions from binding to the pump and blocks acid secretion...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38596486/current-considerations-on-intraductal-papillary-neoplasms-of-the-bile-duct-and-pancreatic-duct
#36
JOURNAL ARTICLE
Efstathios T Pavlidis, Ioannis N Galanis, Theodoros E Pavlidis
Pancreatobiliary intraductal papillary neoplasms (IPNs) represent precursors of pancreatic cancer or bile duct cholangiocarcinoma that can be detected and treated. Despite advances in diagnostic methods, identifying these premalignant lesions is still challenging for treatment providers. Modern imaging, biomarkers and molecular tests for genomic alterations can be used for diagnosis and follow-up. Surgical intervention in combination with new chemotherapeutic agents is considered the optimal treatment for malignant cases...
March 14, 2024: World Journal of Gastroenterology: WJG
https://read.qxmd.com/read/38594430/red-blood-cell-distribution-width-as-a-risk-factor-for-30-90-day-mortality-in-patients-with-gastrointestinal-bleeding-analysis-of-the-mimic-iv-database
#37
JOURNAL ARTICLE
Yu Chen, Yang Chen, Li Ming, Tan Shiyun
PURPOSE: The purpose of this research was to assess the relationship between red blood cell distribution width (RDW) and mortality in patients with gastrointestinal (GIB) bleeding in the intensive care unit (ICU). METHODS: The information of the participants was obtained from the Medical Information Mart for Intensive Care IV database. The main outcome of this research was 30/90-day mortality, with ICU mortality and in-hospital mortality as secondary outcomes...
April 9, 2024: Digestive Diseases and Sciences
https://read.qxmd.com/read/38584510/germline-testing-and-genetic-counselling-in-biliary-tract-cancer-an-operative-proposal-to-improve-the-state-of-art
#38
JOURNAL ARTICLE
Margherita Rimini, Silvia Presi, Giovanni Battista Pipitone, Annalisa Russo Raucci, Francesca Ratti, Angelo Della Corte, Federica Pedica, Giuseppe Vanella, Giovanni Tonon, Valentina Burgio, Francesco Vitiello, Federico Rossari, Elisabeth Amadeo, Maria Giulia Cangi, Lorenza Pecciarini, Paolo Giorgio Arcidiacono, Francesca Falcinelli, Stefano Cascinu, Francesco De Cobelli, Luca Aldrighetti, Maria Grazia Patricelli, Paola Carrera, Andrea Casadei-Gardini
INTRODUCTION: A genetic predisposition seems to be involved in biliary tract cancer, but the prevalence of germline mutations in BTC remains unclear, and the therapeutic role of the germline pathologic variants is still unknown. AREA COVERED: The aim of the present work is to systematically review the data available on the hereditary predisposition of biliary tract cancer by a specific research on PubMed, in order to highlight the most important critical points and to define the current possible role of germinal testing and genetic counseling in this setting of patients...
April 8, 2024: Expert Review of Gastroenterology & Hepatology
https://read.qxmd.com/read/38583603/high-risk-smoking-in-the-united-states-nicotine-staining-predicts-increased-colonic-adenomas-and-advanced-adenomas-on-colonoscopy
#39
JOURNAL ARTICLE
Christopher Bouvette, Justin Kosirog, Bryce Yohannan, Alyssa Grossen, Ijlal Akbar Ali, Mohammad Madhoun
BACKGROUND: Smoking is linked with numerous adverse health effects. Nicotine staining on fingers or teeth is thought to suggest active or heavy smoking. The significance of nicotine staining within gastroenterology remains unclear. AIM: We set out to establish the predictive value of nicotine staining for adenomas and advanced adenomas. METHODS: This was a cross-section study of patients who underwent colonoscopy at the Oklahoma City Veterans Affairs Medical Center from November 2019 to November 2020...
April 5, 2024: Preventive Medicine
https://read.qxmd.com/read/38582270/an-immunocompetent-mongolian-gerbil-model-for-hepatitis-e-virus-genotype-1-infection
#40
JOURNAL ARTICLE
Tianxu Liu, Qiyu He, Xinyue Yang, Yuebao Li, Disen Yuan, Qinghui Lu, Tianyu Tang, Guiwe Guan, Liwei Zheng, He Zhang, Changyou Xia, Xin Yin, Guochao Wei, Xiangmei Chen, Fengmin Lu, Lin Wang
BACKGROUND & AIMS: Hepatitis E virus (HEV), primarily genotype 1 (HEV-1), causes approximately 20.1 million infections, 44000 deaths, and 3000 stillbirths annually. Current evidence indicates that HEV-1 is only transmitted in humans. Here, we evaluated whether Mongolian gerbils can serve as animal models for HEV-1 infection. METHODS: Mongolian gerbils were used for HEV-1 and HEV-3 infection experiments. HEV infection parameters, including detection of HEV RNA and HEV antigen, liver function assessment, and histopathology, were evaluated...
April 5, 2024: Gastroenterology
keyword
keyword
56362
2
3
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.